Glenn McGrath
We initiated a randomized placebo-controlled phase 1-2 trial to evaluate the safety and immunogenicity of the rSARS-CoV-2 vaccine…
Friday, January 7, 2022
Edit
Showing posts with label McGrath. Show all posts
Showing posts with label McGrath. Show all posts
Subscribe to:
Posts (Atom)